Home / Intelligence / Scientific Publications / Systemic Literature Review to Characterize the Burden and Unmet Needs Associated with Cremophor EL
Cremophor EL (CrEL) is an additive (excipient) used to improve the solubility of hydrophobic drugs including certain anti-cancer drugs, like paclitaxel. Although the potential toxicities associated with CrEL are well known, the burden of CrEL-containing therapy is not well defined in the published scientific literature.
Brixner D, McKinley K, Gelder M, Oak B, Dehipawala S, Hadker N
ISPOR Meeting 2021
Sign up for the latest intelligence